TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial

TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial

Abstract Background Evidence increases that a high or a standard dose of tranexamic acid (TA) reduces postpartum bleeding. The TRACES pharmacobiological substudy aims to establish a therapeutic strategy in hemorrhagic (H) Cesarean section (CS) with respect to the intensity of fibrinolysis by using i...

Full description

Bibliographic Details
Main Authors: Anne-Sophie Ducloy-Bouthors, Emmanuelle Jeanpierre, Imen Saidi, Anne-Sophie Baptiste, Elodie Simon, Damien Lannoy, Alain Duhamel, Delphine Allorge, Sophie Susen, Benjamin Hennart
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Trials
Subjects:
Postpartum hemorrhage
Cesarean section
Fibrinolysis
Tranexamic acid
Pharmacokinetics
Plasmin
Online Access:http://link.springer.com/article/10.1186/s13063-017-2421-6

Internet

http://link.springer.com/article/10.1186/s13063-017-2421-6

Similar Items